NASDAQ$TELA
TELA Bio Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
TELA Bio's revenue increased by 45% year-over-year, driven by commercial expansion and market penetration.
TELA Bio reported a revenue of $11.9 million for Q1 2023, a 45% increase compared to the same period in 2022. The company's gross profit was $7.9 million, representing 66% of revenue. Despite an operating loss of $11.3 million and a net loss of $12.0 million, the company anticipates revenue growth and surgeon adoption to accelerate throughout the remainder of 2023.
- Revenue increased by 45% year-over-year, reaching $11.9 million in Q1 2023.
- Gross profit was $7.9 million, or 66% of revenue, compared to $5.0 million, or 61% of revenue, in the same period in 2022.
- Operating expenses increased to $19.2 million, driven by higher compensation and employee-related expenses.
- Cash and cash equivalents totaled $30.1 million as of March 31, 2023.
Headline financials
Revenue & EPS history
TELA Bio · Revenue · Quarterly
$11.9M
Forward guidance
The company expects full year 2023 revenue to range from $60 million to $65 million, reflecting growth of 45% to 57% over full year 2022.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2023
-2.5%
Avg return
Earnings day
-3.7%
Avg return
5 days after
+3.7%
Avg return
30 days after
42%
11 / 26 earnings
Positive
+20.2%
Q1 2024
Best reaction
-37.2%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -5.3% | -18.6% | — | |
| Q4 2025 | +1.7% | -25.8% | -12.0% | |
| Q3 2025 | -9.3% | -2.7% | +3.6% | |
| Q1 2025 | +7.2% | -0.1% | +90.7% | |
| Q4 2024 | -37.2% | -44.9% | -59.1% | |
| Q3 2024 | +2.0% | +3.0% | -1.7% | |
| Q2 2024 | -23.9% | -23.4% | -35.0% | |
| Q1 2024 | +20.2% | +21.2% | +16.7% | |
| Q4 2023 | +4.0% | +0.9% | -13.8% | |
| Q3 2023 | -20.3% | -21.7% | -4.5% | |
| Q2 2023 | -4.8% | -1.2% | -2.8% | |
| Q1 2023 | -3.6% | -4.8% | +11.2% | |
| Q4 2022 | -5.5% | -3.7% | -11.3% | |
| Q3 2022 | +13.8% | +11.2% | +44.7% | |
| Q2 2022 | -6.5% | +5.5% | +0.9% | |
| Q1 2022 | -5.7% | -7.0% | -31.4% | |
| Q4 2021 | -4.8% | -4.8% | -20.4% | |
| Q3 2021 | -3.8% | -3.7% | -1.7% | |
| Q2 2021 | +5.0% | +4.4% | -8.3% | |
| Q1 2021 | +3.2% | +11.5% | +5.9% | |
| Q4 2020 | -6.6% | +0.9% | -1.8% | |
| Q3 2020 | -3.5% | -0.8% | -3.6% | |
| Q2 2020 | +5.4% | +4.1% | +20.7% | |
| Q1 2020 | -2.4% | -3.6% | +38.6% | |
| Q4 2019 | +0.6% | -0.4% | +34.0% | |
| Q3 2019 | +13.9% | +8.8% | +32.6% | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro